» Articles » PMID: 30679985

Pemphigoid Nodularis - Rare Presentation of Bullous Pemphigoid: A Case Report and Literature Review

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2019 Jan 26
PMID 30679985
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Pemphigoid nodularis (PN) is a rare clinical variant of bullous pemphigoid characterized by the presence of nodular prurigo-like lesions and pemphigoid blisters. The diagnosis is confirmed by direct immunofluorescence (DIF)/ indirect immunofluorescence (IIF) and immunoserology tests. For some patients, with long mean duration of symptoms, the correct diagnosis of PN is delayed because the disease is not recognized. We present a case and summarize the reported characteristics of PN. The search in MEDLINE database, after selection, resulted in 36 articles presenting 47 cases of PN. Between published cases a female predominance was noted (female to male ratio of 1.8:1), almost half of the reported patients were non-Caucasian, and the mean age at presentation was 66.2 years. The mean duration until the diagnosis was almost 2 years. Sixteen patients also had other autoimmune diseases. Twenty-two patients developed vesicles/bullae/urticarial plaques before or after the diagnosis. Peripheral eosinophilia and high levels of serum total IgE were reported in 10.6 and 27.2% of patients, respectively. ELISA for either BP180, BP230 or both were positive in all tested cases. DIF and IIF microscopy were positive overall in 100 and 92.3% of cases, respectively. Corticosteroids, either topical or systemic, were the most efficient therapeutic option, although many others were used. PN remains a diagnostic and therapeutic challenge in elderly patients with unexplained refractory chronic pruritus associated with papulo-nodular lesions.

Citing Articles

Imiquimod-induced bullous pemphigoid: A case report.

Li H, Aw M, Glassman S SAGE Open Med Case Rep. 2023; 11:2050313X231164222.

PMID: 37025248 PMC: 10071145. DOI: 10.1177/2050313X231164222.


Case Report: Pemphigoid Nodularis-Five Patients With Many Years of Follow-Up and Review of the Literature.

Szymanski K, Adaszewska A, Jakubowska B, Kowalewski C, Pietrzyk E, Wozniak K Front Immunol. 2022; 13:885023.

PMID: 35493472 PMC: 9039219. DOI: 10.3389/fimmu.2022.885023.


Persistent Widespread Pruritic Nodules: A Quiz.

Hu H, Yang W, Li J, Guo H Acta Derm Venereol. 2021; 101(8):adv00519.

PMID: 34230979 PMC: 9425603. DOI: 10.2340/00015555-3869.


The Second Conference of the Romanian Society of Immuno-Dermatology, Bucharest, September 27-29, 2018.

Boda D, Tsatsakis A Exp Ther Med. 2019; 17(2):979-981.

PMID: 30679962 PMC: 6327649. DOI: 10.3892/etm.2018.7067.

References
1.
Ameen M, Harman K, Black M . Pemphigoid nodularis associated with nifedipine. Br J Dermatol. 2000; 142(3):575-7. DOI: 10.1046/j.1365-2133.2000.03389.x. View

2.
Gao X, Lin J, Yang C, Ma L, Wang G, Wang Y . A case of Kaposi's sarcoma associated with pemphigoid nodularis. J Dermatol. 2001; 28(7):388-92. DOI: 10.1111/j.1346-8138.2001.tb00155.x. View

3.
Schachter M, Brieva J, Jones J, Zillikens D, Skrobek C, Chan L . Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile. J Am Acad Dermatol. 2001; 45(5):747-54. DOI: 10.1067/mjd.2001.116229. View

4.
Powell A, Albert S, Gratian M, Bittencourt R, Bhogal B, Black M . Pemphigoid nodularis (non-bullous): a clinicopathological study of five cases. Br J Dermatol. 2002; 147(2):343-9. DOI: 10.1046/j.1365-2133.2002.04754.x. View

5.
Ross J, McKee P, Smith N, Shimizu H, Griffiths W, Bhogal B . Unusual variants of pemphigoid: from pruritus to pemphigoid nodularis. J Cutan Pathol. 1992; 19(3):212-6. DOI: 10.1111/j.1600-0560.1992.tb01661.x. View